We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CELZ market cap is 6.06M. The company's latest EPS is USD -3.8253 and P/E is -1.15.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 19k | 0 | 0 | 6k | 3k |
| Operating Income | -6.28M | -1.11M | -1.19M | -1.54M | -1.77M |
| Net Income | -6.22M | -1.05M | -1.1M | -1.45M | -1.68M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 166k | 165k | 88k | 89k | 9k |
| Operating Income | -1.13M | -1.12M | -3.13M | -10.24M | -5.62M |
| Net Income | -8.48M | -36.33M | 19.21M | -10.14M | -5.29M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 19.19M | 15.23M | 14.13M | 12.51M | 10.72M |
| Total Liabilities | 3.32M | 407k | 398k | 421k | 371k |
| Total Equity | 15.87M | 14.82M | 13.73M | 12.09M | 10.34M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 531k | 718k | 11.27M | 19.19M | 10.72M |
| Total Liabilities | 8.6M | 40.52M | 1.05M | 3.32M | 371k |
| Total Equity | -8.07M | -39.8M | 10.22M | 15.87M | 10.34M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.8M | -3.84M | -4.83M | -6.13M | -8.03M |
| Investing | -10.08M | 5.04M | 497k | 2.32M | 3.45M |
| Financing | 15.47M | N/A | N/A | N/A | -271k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.21M | -435k | -2.22M | -7.8M | -8.03M |
| Investing | N/A | -250k | N/A | -10.08M | 3.45M |
| Financing | 998k | 694k | 12.84M | 15.47M | -271k |
| Market Cap | 6.06M |
| Price to Earnings Ratio | -1.15 |
| Price to Sales Ratio | 673.85 |
| Price to Cash Ratio | 1.75 |
| Price to Book Ratio | 0.59 |
| Dividend Yield | - |
| Shares Outstanding | 1.38M |
| Average Volume (1 week) | 2.69k |
| Average Volume (1 Month) | 3.21k |
| 52 Week Change | -23.99% |
| 52 Week High | 10.2812 |
| 52 Week Low | 3.93 |
| Spread (Intraday) | 0.77 (15.19%) |
| Company Name | Creative Medical Technology Holdings Inc |
| Address |
112 north curry street carson city, nevada 89703 4934 |
| Website | https://www.creativemedicaltechnology.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
